Products and Resources Catalog

There are thousands of people in recovery from addiction unaware of their civil rights under the ADA. The ADA insures that people with addiction to alcohol, and in recovery from opioids and other drugs have the same rights and opportunities as everyone else. Find out how the ADA addresses alcohol and substance use disorders differently. This session will also introduce how the ADA applies to addiction in three phases of employment: pre-offer, post-offer, and employment. These differences will be illustrated with scenarios about alcohol, opioids, cocaine, and marijuana. Learning Objectives: Understand the ADA’s definition of disability and how it applies to addiction and recovery. Distinguish how the ADA applies to people with addiction to alcohol and those in recovery from opioids and other drugs. Learn which protections the ADA provides in access to employment, state and local government services, and places of public accommodations. Who is encouraged to attend? Clinicians, providers, administrators, and leadership are highly encouraged to participate to learn more about ADA protection rights.   Additional Resources ADA Webinar Handouts   Presenter: Oce Harrison, Ed.D. Dr. Harrison is the Project Director at the New England ADA and has directed the New England ADA Center since 2001. Dr. Harrison provides ADA, Addiction and Recovery trainings throughout New England.  She has presented at SAMHSA’s New England Addiction Training and Technology Center; the National Association for Addiction Counselors (NAADAC) 2019 annual Conference; Massachusetts Organization for Addiction and Recovery (MOAR); and in 25 city and town meetings in Massachusetts on behalf of family support chapters of Learn to Cope. She led the ADA National Networks’ ADA, Addiction and Recovery Committee which has produced a fact sheet series on how the ADA addresses addiction and recovery. Dr. Harrison is known for her initiation, follow-through skills and congeniality. Before coming to the New England ADA Center, Dr. Harrison worked with organizations such as: the Boston Self Help Center, Mass General Hospital’s Burn Unit, Perkins School for the Blind, Casa Esperanza, and the Institute for Community Inclusion at Children’s Hospital. She earned her doctorate at Boston University’s School of Education in 1994. Oce is a person living with a disability.

This FREE 2-part virtual learning series was designed to enhance education and training related to the pre and post migration risk factors that contribute to substance use disorders (SUD) among Hispanic/Latino immigrant youth and provides screening, intervention, and referral to treatment tools to non-clinical professionals working with this population. The series addresses research data related to SUD in Hispanic/Latino immigrant youth, introduces basic alcohol, tobacco, and other drug abuse (ATODA) training, focuses on the early identification and prevention of behavioral, and emotional problems, as well as identifying signs and symptoms of co-occurring mental health issues. The series also provides information on assessing early signs and symptoms of SUD and highlights the importance of basic parenting/caregiver supervision and monitoring for those caring for unaccompanied immigrant youth. Lastly, the presenters will discuss developmental and SUD related issues, and introduces a culturally adapted approach to delivering Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Hispanic/Latino immigrant youth. At the end of the 2-part virtual learning series, non-clinical professionals will have reviewed the dynamics of facilitating a culturally responsive SBIRT intervention in preventing, eliminating substance use, and supporting healthy adjustment and wellbeing in Hispanic/Latino immigrant youth. Session 1: Early Identification of Pre and Post Migration Risk Factors of Substance Use Disorders in Hispanic/Latino Youth Date: December 1st, 2022 Time: 12:00pm-1:30pm MST/ 2:00pm-3:30pm ET   View Presentation Download Presentation Handouts Learning Objectives: Participants will be able to: Understand basic ATODA use and abuse data as it relates to the general population compared to Hispanic/Latino immigrant youth Assess and identify pre and post migration trauma in early identification and co-occurring issues in relation to substance use in the Hispanic/Latino immigrant youth Assess behavioral and emotional problems in early identification and prevention of substance use in Hispanic/Latino immigrant youth Identify parenting related issues to promote positive parenting skills in the prevention of substance use in the Hispanic/Latino youth population   Session 2: A Migration Informed Context for Delivering Screening, Brief Intervention, and Referral to Treatment (SBIRT) with Hispanic/Latino Immigrant Youth Date: January 12th, 2023 Time: 12:00pm-1:30pm MST/ 2:00pm-3:30pm ET   View Presentation Download Presentation Handouts Learning Objectives: Participants will be able to: List migration related experiences that impact development and coping with immigrant youth Define cultural bereavement and its correlation with substance use Describe components of, Screening, Brief Intervention, and Referral to Treatment, (SBIRT) Identify opportunities for cultural adaptations with SBIRT with immigrant youth Identify factors of a culturally responsive rapport and engagement for screening List benefits of the person-centered approach using core skills of motivational interviewing in a brief intervention interaction List cultural considerations for a referral to treatment and language conducive terminology   About the Presenters Richard Cervantes, Ph.D. Dr. Cervantes is Research Director of Behavioral Assessment, Inc. Dr. Cervantes was a Research Psychologist at the UCLA Spanish Speaking Mental Health Research Center and held a full-time faculty appointment in the USC School of Medicine, Department of Psychiatry, and the Behavioral Sciences. Dr. Cervantes is Co-Investigator on the Duke University, NIH Supported “Ser Hispano” study on acculturation stress and biomarkers. He was also the Principal Investigator for the NIH funded study, “Development of the Hispanic Stress Inventory-2” and PI on the recently completed the NIH drug prevention study “Familia Adelante: A multi risk Prevention Program for Hispanic Youth”. Dr. Cervantes is also a leader in evaluation science with special expertise in cultural competency and cross-cultural instrument development. He is the lead evaluator for the SAMHSA Hispanic and Latino Addiction and Prevention Technology Transfer Centers (TTCs). He has published extensively in peer review journals, books, and special reports. He is on the editorial board for the Hispanic Journal of Behavioral Sciences and sits on a number of national, local and university based advisory boards. Dr. Cervantes received his Ph.D. in Clinical Psychology from Oklahoma State University.   Diana Padilla, CLC, CARC, CASAC-T Diana Padilla, RCR, CASAC-T, is Research Project Manager at the New York State Psychiatric Institute, Division of Substance Use Disorders, Columbia University Medical Center. Ms. Padilla provides intensive technical assistance in two organizational capacity-building initiatives; the implementation of SBIRT (Screening, Brief Intervention, and Referral to Treatment), and the integration of Equity and Inclusion strategies to improve service delivery and address behavioral health disparities for marginalized communities. Both projects are facilitated for the Northeast and Caribbean Technology Transfer Center (NeCATTC), HHS Region 2. Ms. Padilla also Chairs the National Committee on Behavioral Health Equity & Inclusion committee for the Addiction Technology Transfer Center. The working group focuses on disseminating the application of CLAS standards and other related topics and technical assistance initiatives to help organizations address disparities in behavioral health care. Ms. Padilla is also a Senior Trainer with more than 23 years of public health service, instructing behavioral health practitioners, prevention specialists and drug court professionals on addictions and recovery supporting best practices.

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. September 22, 2022 Presenter: Evan Burke, Idaho Harm Reduction Project In this session, Evan Burke will provide an overview of harm reduction informed practices that can be incorporated into an individual’s drug use to reduce their risk of overdose. Read more about this session and its presenter. Watch the recording | Download slides

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. Part 1: September 7, 2022 Presenters: Evan Burke (Idaho Harm Reduction Project) and Norma Jaeger (Recovery Idaho) In this session, Evan Burke offered a brief overview of the data on opioid overdose in Idaho and the response to it by government and community-based organizations. Burke also covered how to recognize and respond to an overdose and provide guidance about harm reduction informed practices. Norma Jaeger talked about the RxAware Program, which will address risks associated with opioids and pain management. Read more about this session and its presenters.  Watch the recording | Download slides | RxAware toolkit | RxAware flyer

This presentation reviewed the philosophy of harm reduction as an intervention for substance use disorder and will examine the trajectory of harm reduction programming in Idaho since the legalization of syringe services in 2019.  A few learning objectives:  Be able to identify multiple forms of harm reduction as it pertains to a variety of potentially risky behaviors. Be able to reframe substance use from a harm reduction model. Be able to identify the benefits of a syringe service program and other harm reduction interventions to an individual and a community. Increase knowledge about the implementation and growth of harm reduction programs in Idaho. About the presenter: Marjorie Wilson, LMSW, MPH, is the Executive Director and co-founder of Idaho Harm Reduction Project (IHRP). IHRP is a drug user health program offering a syringe service program, naloxone distribution program, and HIV/HCV testing. Since 2019, IHRP has served the whole state through its mail-based services and has distributed supplies into all of Idaho's 44 counties. Download slides | Watch recording

This 2.5 hour self-paced course provides an overview of Medications for Addiction Treatment (MAT) and discusses how MAT fits into the context of the larger substance use disorder treatment system. It includes information on the scale of the alcohol and opioid problem in the U.S. as well as how alcohol and opioids work in the body and brain. The overall purpose of this course is to enhance your professional knowledge of MAT and increase your confidence to engage and educate patients about MAT. 2.5 hours Continuing Education Available, NAADAC, NASW, CNE

La falta de aceptación puede interferir con los atentos de ampliar el uso de tratamientos asistidos por medicamentos (TAM) para los trastornos por consumo de sustancias (TCS). Las Hojas Informativas de TAM ofrecen estrategias para generar apoyo para esta práctica basada en evidencia.  Hoja Informativa #1: Asegurando la Aceptación              Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación              Hoja Informativa #3: Abogando por las Medicamentos 

Lack of buy-in can interfere with attempts to expand use of medication-assisted treatment (MAT) for substance use disorders. These three fact sheets offer strategies to build support for this evidence-based practice.  MAT Fact Sheet #1: Securing Buy-in            MAT Fact Sheet #2: Reducing Risk of Misuse and Diversion          MAT Fact Sheet #3: Making the Case for Medication

Through the "One Pill Can Kill" campaign, the DEA is bringing awareness to the dangers of fentanyl, the threat of fake pills, and resources to keep people safe. The overarching goal was to provide participants with information about the "One Pill Can Kill" campaign and review a best practice communication strategy so participants felt confident in both their knowledge of the "One Pill Can Kill" campaign and in their ability to communicate it with others.   Learning Objectives Gain knowledge on the dangers of fentanyl Describe 3 key messages of the "One Pill Can Kill" awareness campaign Be familiar with resources to support the "One Pill Can Kill" campaign Review a best-practice communication strategy for sharing information Speakers Sean T. Fearns serves as the Chief of Community Outreach and Prevention Support for DEA since 2015.  In this capacity, Sean is responsible for guiding a diverse and creative staff to develop and implement strategic national partnerships with other organizations which help educate the public on the current drug threats facing the country, support the DEA field divisions, implement DEA’s Operation Engage, communicate key administration drug prevention messages, and help reduce the demand for those drugs.       Alex Waitt, MS, MSEd, LPC, is a licensed professional counselor and the Co-Project Director for the Central East ATTC where he is responsible for the programmatic and administrative coordination of all training and technical assistance for the CE ATTC Region. He is the spokesperson and liaison to stakeholders and supports the development of other training and workforce initiatives.           RESOURCES One Pill Can Kill DEA Campaign Webinar slides This webinar was provided by the Central East ATTC. The Central East ATTC is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and managed by the Danya Institute.

In partnership with Brown University SciToons and the Department of Emergency Medicine, the New England ATTC created the product "Opioid Overdose Rescue: 5 Ways to Save the Life." This educational video teaches the viewer how to recognize an overdose and how to effectively intervene. Watch the video to learn more. 

The Naloxone is an Act of Love website was developed with support by the New England Addiction Technology Transfer Center (ATTC) in partnership with the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose. The website hosts a suite of resources designed to reduce stigma surrounding the use of naloxone and those who experience an opioid overdose along with encouraging viewers to get trained in and carry Naloxone. Specific resources include narrative videos, posters, and coasters. 

This snapshot is intended to bring awareness to individuals, families, professionals, and providers about the serious substance use disorder problem among the Hispanic and Latino Veteran population. Español LOS VETERANOS Y LOS TRASTORNOS EN CONSUMO DE SUSTANCIAS Esta reseña infomativa tiene como objetivo proporcionar recursos a individuos, padres, profesionales y proveedores sobre el grave problema del trastorno por uso de sustancias en la población de Veteranos Hispanos y Latinos Português VETERANOS HISPÂNICOS E LATINOS E TRANSTORNOS POR USO DE SUBSTÂNCIAS (TUS) Esta síntese de informações destina-se a fornecer recursos para indivíduos, familiares, profissionais e provedores sobre o grave problema de transtorno por uso de substâncias entre a população hispânica e latina veterana.

The July 2022 Dialogue contains articles on: Addiction: Construction Work and Opioids | Mental Health: Mental Health in the BIPOC Community | Prevention: BIPOC Mental Health Month | ORN: Diversity, Equity, and Inclusion. Additional sections include behavioral health observances, virtual training and webinar events, Region 3 news, new resources, and Regional Spotlight: PPW Addiction Treatment Center – Claymont Center for Pregnant & Parenting Women. Additional sections include upcoming training and webinar events, behavioral health observances, new resources, and Region 3 news. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated bi-monthly on the first Tuesday. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter, [email protected]. Sign up to receive the Dialogue in your mailbox. Visit the Dialogue Archives.

This webinar, presented by Gail D'Onofrio, MD, focused on the crucial role of the emergency department (ED) in recognizing and treating opioid use disorder (OUD) patients with evidence-based medications for addiction treatment. The opioid epidemic combined with the COVID-19 pandemic has greatly escalated the need to mitigate the morbidity and mortality associated with rising rates of fentanyl use. Dr. D'Onofrio shared data supporting the use of buprenorphine in the ED and discussed the consequences of not initiating treatment, barriers to implementation of ED buprenorphine, and components of successful integration of an ED program with community partnerships. She also shared current research by emergency physicians regarding innovative strategies like high-dose induction and use of an extended release 7-day formulation of buprenorphine. Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network. Download slides | Watch recording

Harm reduction is any action that reduces risk and increases personal and public safety. Harm reduction approaches have proven to prevent death, injury, disease, overdose, prevent substance misuse or disorder and most of us practice harm reduction techniques daily. For example, when we wear a seatbelt or apply sunscreen we are using harm reduction strategies.  Fentanyl strips, naloxone, and needle exchange programs are also examples of harm reduction.  This poster identifies some of the most common harm reduction methods in an attempt to normalize the term "harm reduction" and broaden the definition.   The Spanish translations were prepared by consultants for the Mountain Plains ATTC. While reasonable efforts are made to provide accurate translations, acknowledging the diversity of Spanish and English Language, some words/phrases may differ.   The poster can be downloaded in multiple formats directly from the MPATTC website. This product was designed for display as an 11x17 sized poster in a location most visible and accessible to behavioral health providers, educators, and/or peer recovery specialists but is also available in an 8.5x11 format for in-house printing. In addition, hard copies may be requested from the MPATTC by emailing us at [email protected] (posters can be mailed within the continental United States). Please click on the link below for more information.   To request an 11x17 "What is Harm Reduction?" poster to be mailed directly to you, please click "REQUEST A HARD COPY".  

Fatal overdoses are skyrocketing, and rates of substance use remain high, demonstrating the need to expand substance use disorder (SUD) treatment. In 2020, fatal overdoses in the Central East increased 25% (from 9,909 to 12,377), with overdose rates above the national average in every state except Virginia. Rates of substance use and SUD are persistently elevated. Funding additional treatment services and expanding access to existing treatment can help address the problem. This factsheet provides statistics and justifications for increasing SUD treatment.

The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.   Alcohol is STILL a Drug: An Exploratory Webinar Series (May 3, 2022) Recording     DESCRIPTION  Alcohol is STILL a drug.  The opioid crisis, increase in stimulant misuse, and marijuana legalization dominate the news— yet alcohol remains the number one substance causing health, social, legal and financial problems throughout the US. While this series will focus on the hopefulness of recovery from alcohol use disorder, we’ll also take a deep dive into what we know about the full impact of alcohol overuse and the ways it affects every person in the US.     SPEAKER Gabriela Zapata-Alma, LCSW, CADC Gabriela Zapata-Alma, LCSW, CADC, is the Associate Director at the National Center on Domestic Violence, Trauma, and Mental Health, as well as a lecturer at the University of Chicago, where they direct the Alcohol and Other Drug Counselor Training Program. Gabriela brings over 15 years of experience supporting people impacted by structural and interpersonal violence and their traumatic effects through evidence-based clinical, housing, resource advocacy, and HIV-specific integrated care programs. Currently, Gabriela authors best practices, leads national capacity-building efforts, and provides trauma-informed policy consultation to advance health equity and social justice.     SERIES LEARNING OBJECTIVES These are the overall learning objectives for the full 10-session series:  Summarize the current impacts of problematic alcohol use in various/special populations, including pregnant women, youth, rural, and minority populations.  Assess and prioritize alcohol reduction efforts in targeted settings.  Describe the current efforts to curb problematic alcohol use, including best practices in providing treatment. 

Alcohol is STILL a Drug: An Exploratory Webinar Series: March 1, 2022, Recording   The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.     DESCRIPTION  Alcohol is STILL a drug.  The opioid crisis, increase in stimulant misuse, and marijuana legalization dominate the news— yet alcohol remains the number one substance causing health, social, legal and financial problems throughout the US.    While this series will focus on the hopefulness of recovery from alcohol use disorder, we’ll also take a deep dive into what we know about the full impact of alcohol overuse and the ways it affects every person in the US.   This session will provide an introduction to Fetal Alcohol Spectrum Disorders (FASD) including general information about the risks of alcohol intake during pregnancy, the negative impact on the developing fetus, as well as how to prevent it.     SERIES LEARNING OBJECTIVES These are the overall learning objectives for the full 10-session series:  Summarize the current impacts of problematic alcohol use in various/special populations, including pregnant women, youth, rural, and minority populations.  Assess and prioritize alcohol reduction efforts in targeted settings.  Describe the current efforts to curb problematic alcohol use, including best practices in providing treatment.        TRAINER     Lisa Rahm, BS, CMP Lisa Rahm is the Special Initiatives Manager for Prevention First. She has 28 years of experience in the education and human services fields with the last 21 years at Prevention First. In her current position, she has developed, implemented, and evaluated special initiatives such as FASD Screening and Brief Intervention Project, and Statewide FASD Project as well as overseeing conferences, meeting planning, and special events. Rahm holds a Bachelor of Science in Organizational Leadership from Greenville College and holds the certification as a Certified Meeting Professional (CMP).

The New England ATTC co-hosted the Recovery Science and Harm Reduction (RSHR) Reading Group meeting on February 24, 2022 from 12:30 PM to 1:30 PM. This discussion reviewed the article, “Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System.”  View the February 2022 RSHR Reading group meeting summary that includes a brief article summary and key themes that arose in discussion with the participants.

The November 2021 Dialogue contains articles on: Addiction: Native Americans & the Opioid Crisis | Mental Health: Spread Kindness | Prevention: Veterans and Substance Use Prevention | ORN: Mobile Clinics Reach Rural Areas | Spotlight: Dr. Ala Stanford Center for Health Equity (ASHE). Additional sections include upcoming training and webinar events, behavioral health observances, new resources, and Region 3 news. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated bi-monthly on the first Tuesday. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter, [email protected]. Sign up to receive the Dialogue in your mailbox. Visit the Dialogue Archives.

The New England ATTC co-hosted the Recovery Science and Harm Reduction (RSHR) Reading Group meeting on August 19, 2021 from 12:30 PM to 1:30 PM. This discussion reviewed the article, “"It’s not just injecting drugs”: Supervised consumption sites and the social determinants of health.”  View the August 2021 RSHR Reading group meeting summary that includes a brief article summary and key themes that arose in discussion with the participants.

These Telehealth MOUD Video Demonstrations show distinct clinical interactions common across the medications for opioid use disorder (MOUD) modality. Except for the first two videos listed (Buprenorphine Induction and Re-induction to Buprenorphine), which show the same mock patient at two stages along his treatment trajectory, the videos in this collection are independent depictions showcasing different settings, patient situations, and provider types. The common thread for these videos is that each patient portrayed has an opioid use disorder and is considering or engaged in medication treatment. This set of videos may be useful for individuals entering the MOUD workforce or for MOUD patients and family members curious about what happens at various points in treatment.  Produced by the Northwest ATTC (SAMHSA grant no. TI080201), in co-sponsorship with Southeast ATTC (SAMHSA grant no. TI080215) and the ATTC Network Coordinating Office (SAMHSA grant no. TI080205). We thank the clinicians involved for their conceptual contributions to the development of these characters and the clinical scenario.

This month our National Hispanic and Latino ATTC and PTTC would like to support August’s Overdose Awareness Month and International Overdose Awareness Day, which takes place annually on August 31st.   Resources: https://salud-america.org/drug-overdose-deaths-during-covid-19-a-historical-spike-among-latinos/    www.overdoseday.com #NLBHA #NHLATTC #NHLPTTC Español  Nuestros Centros Nacionales Hispano y Latino ATTC y PTTC desean apoyar el Mes de Concientización de Sobredosis de el mes de agosto y el Día Internacional de Concientización de Sobredosis, que tiene lugar anualmente el 31 de agosto.   Recursos: https://salud-america.org/drug-overdose-deaths-during-covid-19-a-historical-spike-among-latinos/    www.overdoseday.com #NLBHA #NHLATTC #NHLPTTC Português Neste mês, nós gostaríamos de apoiar o Mês de Conscientização sobre a Overdose e o Dia Internacional de Conscientização sobre a Overdose, que ocorre anualmente em 31 de agosto.   Recursos: https://salud-america.org/drug-overdose-deaths-during-covid-19-a-historical-spike-among-latinos/    www.overdoseday.com #NLBHA #NHLATTC #NHLPTTC

Presenter: Jenna van Draanen, PhD, MPH, University of Washington July 2021 This one-hour webinar discussed the role of harm reduction in addiction treatment and how it fits with other systems of care. In addition to covering recent service use patterns in the Northwest, Dr. van Draanen shared evidence and lessons learned from her work with overdose prevention sites (a model of peer-run safe consumption sites) in Vancouver, Canada. The session covered changes in overdose prevention site utilization during COVID-19, the importance of peer involvement in service delivery, and outcomes associated with overdose prevention site utilization. Download slides